S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
NYSE:CAH

Cardinal Health (CAH) Stock Forecast, Price & News

$55.61
+0.63 (+1.15%)
(As of 05/13/2022 04:00 PM ET)
Add
Compare
Today's Range
$54.80
$55.82
50-Day Range
$52.43
$63.86
52-Week Range
$45.85
$64.53
Volume
91,075 shs
Average Volume
2.99 million shs
Market Capitalization
$15.15 billion
P/E Ratio
8.48
Dividend Yield
3.52%
Beta
0.82
30 days | 90 days | 365 days | Advanced Chart
Receive CAH News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

Cardinal Health logo

About Cardinal Health

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. It has a collaboration agreement with Journey Biosciences, Inc. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

Headlines

Walgreens, Florida settle opioid costs lawsuit for $683M
The Walgreens pharmacy chain has reached a $683 million settlement with the state of Florida in a lawsuit accusing the company of improperly dispensing millions of painkillers that contributed to the opioid crisis
Federal judges are asked to pave way for Purdue Pharma deal
Lawyers for Purdue Pharma, victims of the opioid crisis and governments have asked a federal appeals panel to pave the way for a settlement of claims against the OxyContin maker
Appeals court to consider paving way for Purdue Pharma deal
A federal appeals panel is considering whether to allow a legal move that would pave the way for a settlement between OxyContin maker Purdue Pharma and governments across the U.S. The deal would allow the company to exit bankruptcy and require members of the Sackler family who own it to contribute billions of dollars to help combat the opioid crisis in the U.S. At issue at a hearing Friday before the 2nd U.S. Circuit Court of Appeals in New York is whether a bankruptcy judge has the...
Cardinal Health Raises Quarterly Dividend
StockNews.com Downgrades Cardinal Health (NYSE:CAH) to Buy
TheStreet Lowers Cardinal Health (NYSE:CAH) to D+
See More Headlines

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
Sector
Medical
CUSIP
14149Y10
Employees
47,300
Year Founded
1971

Sales & Book Value

Annual Sales
$162.47 billion
Cash Flow
$8.34 per share
Book Value
($2.54) per share

Profitability

Net Income
$611 million
Pretax Margin
-0.35%

Debt

Price-To-Earnings

Miscellaneous

Free Float
271,310,000
Market Cap
$15.15 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 4/15 Dividend
3/31/2022
Dividend Payable
4/15/2022
Last Earnings
5/05/2022
Today
5/16/2022
Fiscal Year End
6/30/2022
Next Earnings (Estimated)
8/04/2022

Social Links


MarketRank

Overall MarketRank

3.02 out of 5 stars

Medical Sector

15th out of 1,403 stocks

Drugs, Proprietaries, & Sundries Industry

2nd out of 8 stocks

Analyst Opinion: 1.0Community Rank: 4.9Dividend Strength: 5.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -













Cardinal Health (NYSE:CAH) Frequently Asked Questions

Is Cardinal Health a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Cardinal Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View analyst ratings for Cardinal Health
or view top-rated stocks.

When is Cardinal Health's next earnings date?

Cardinal Health is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Cardinal Health
.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings data on Thursday, May, 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.54 by $0.09. The business earned $44.84 billion during the quarter, compared to analysts' expectations of $43.20 billion. Cardinal Health had a negative net margin of 0.54% and a positive trailing twelve-month return on equity of 155.24%. The business's revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.53 earnings per share.
View Cardinal Health's earnings history
.

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Tuesday, May 10th. Stockholders of record on Friday, July 1st will be given a dividend of $0.4957 per share on Friday, July 15th. This represents a $1.98 annualized dividend and a dividend yield of 3.57%. The ex-dividend date of this dividend is Thursday, June 30th. This is a positive change from Cardinal Health's previous quarterly dividend of $0.49.
View Cardinal Health's dividend history
.

Is Cardinal Health a good dividend stock?

Cardinal Health pays an annual dividend of $1.96 per share and currently has a dividend yield of 3.52%. Cardinal Health has been increasing its dividend for 35 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Cardinal Health is 29.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 34.94% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.
View Cardinal Health's dividend history.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY 2022 earnings guidance on Thursday, May, 12th. The company provided earnings per share guidance of $5.15-$5.25 for the period, compared to the consensus EPS estimate of $5.29. The company issued revenue guidance of -.

What price target have analysts set for CAH?

9 brokerages have issued 12-month target prices for Cardinal Health's stock. Their forecasts range from $50.00 to $74.00. On average, they anticipate Cardinal Health's stock price to reach $58.44 in the next year. This suggests a possible upside of 5.1% from the stock's current price.
View analysts' price targets for Cardinal Health
or view top-rated stocks among Wall Street analysts.

Who are Cardinal Health's key executives?
Cardinal Health's management team includes the following people:
  • Mr. Michael C. Kaufmann, CEO & Director (Age 59, Pay $2.28M)
  • Mr. Jason M. Hollar, Chief Financial Officer (Age 49, Pay $1.4M)
  • Ms. Jessica L. Mayer, Chief Legal & Compliance Officer (Age 52, Pay $1.05M)
  • Mr. Stephen M. Mason, Chief Exec. Officer of Medical Segment (Age 50, Pay $1.2M)
  • Mr. Victor L. Crawford, Chief Exec. Officer of Pharmaceutical Segment (Age 60, Pay $1.41M)
  • Ms. Patricia M. English, Sr. VP & Chief Accounting Officer (Age 42)
  • Mr. Brian S. Rice, Chief Information Officer, Exec. VP & Global Bus. Services (Age 59)
  • Mr. Kevin Moran, VP of Investor Relations
  • Dr. Michele A. M. Holcomb Ph.D., Exec. VP of Strategy & Corp. Devel. and Chief Strategy & Bus. Devel. Officer (Age 54)
  • Ms. Ola M. Snow, Chief HR Officer (Age 54) (LinkedIn Profile)
What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health CEO Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among Cardinal Health's employees.

Who are some of Cardinal Health's key competitors?
What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (12.38%), BlackRock Inc. (8.48%), Bank of New York Mellon Corp (2.00%), American Century Companies Inc. (1.73%), Northern Trust Corp (1.35%) and ProShare Advisors LLC (1.14%).
View institutional ownership trends for Cardinal Health
.

Which institutional investors are selling Cardinal Health stock?

CAH stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., American Century Companies Inc., TD Asset Management Inc., Sumitomo Mitsui Trust Holdings Inc., Citigroup Inc., Connor Clark & Lunn Investment Management Ltd., AustralianSuper Pty Ltd, and Arrowstreet Capital Limited Partnership.
View insider buying and selling activity for Cardinal Health
or view top insider-selling stocks.

Which institutional investors are buying Cardinal Health stock?

CAH stock was acquired by a variety of institutional investors in the last quarter, including Equity Investment Corp, BlackRock Inc., Allianz Asset Management GmbH, Federated Hermes Inc., Verity Asset Management Inc., Twin Tree Management LP, National Pension Service, and Victory Capital Management Inc..
View insider buying and selling activity for Cardinal Health
or or view top insider-buying stocks.

How do I buy shares of Cardinal Health?

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $55.61.

How much money does Cardinal Health make?

Cardinal Health has a market capitalization of $15.15 billion and generates $162.47 billion in revenue each year. The company earns $611 million in net income (profit) each year or $6.56 on an earnings per share basis.

How many employees does Cardinal Health have?

Cardinal Health employs 47,300 workers across the globe.

Does Cardinal Health have any subsidiaries?

The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Access Closure Inc., Aero-Med Ltd., Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, AssuraMed Inc., Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 Inc., Cardinal Health 104 LP, Cardinal Health 105 Inc., Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 132 LLC, Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 Inc., Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International India Private Limited, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Medical Products India Private Limited, Cardinal Health Mexico 244 S. de R.L. de C.V., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health Norway AS, Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Poland Spółlka z ograniczonąa odpowiedzialnośsciąa, Cardinal Health Portugal 513 Unipessoal Lda., Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Specialty Pharmacy LLC, Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Cashel Company Unlimited, Cordis Corporation, Cornerstone Rheumatology L.P., Covidien Manufacturing Solutions S.A., Curaspan Health Group Inc., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, GetOutcomes LLC, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies Inc., Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR Italia S.r.l., KPR Switzerland Sales Gmbh, KPR U.S. LLC, Kendall Patient Recovery BVBA, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Limited Liability Company "Cardinal Health Russia", Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Medtronic - Patient Monitoring & Recovery, Mirixa Corporation, MosaicGPO LLC, NaviHealth, Nippon Covidien Ltd., One Cloverleaf LLC, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R.P. Scherer Corporation, RGH Enterprises Inc., RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Subsidiary Name, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Traverse GPO LLC, Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, mscripts, and mscripts LLC.

When was Cardinal Health founded?

Cardinal Health was founded in 1971.

What is Cardinal Health's official website?

The official website for Cardinal Health is www.cardinalhealth.com.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at (614) 757-5000, via email at [email protected], or via fax at 614-757-6000.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.